Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease

被引:0
|
作者
Dagmar E. Ehrnhoefer
Dale D. O. Martin
Mandi E. Schmidt
Xiaofan Qiu
Safia Ladha
Nicholas S. Caron
Niels H. Skotte
Yen T. N. Nguyen
Kuljeet Vaid
Amber L. Southwell
Sabine Engemann
Sonia Franciosi
Michael R. Hayden
机构
[1] University of British Columbia,Centre for Molecular Medicine and Therapeutics (CMMT), CFRI, Department of Medical Genetics
[2] Present address: BioMed X Innovation Center,undefined
来源
Acta Neuropathologica Communications | / 6卷
关键词
Huntington disease; Autophagy; Proteolysis; Caspase; Mutant huntingtin lowering;
D O I
暂无
中图分类号
学科分类号
摘要
Huntington disease (HD) is caused by the expression of mutant huntingtin (mHTT) bearing a polyglutamine expansion. In HD, mHTT accumulation is accompanied by a dysfunction in basal autophagy, which manifests as specific defects in cargo loading during selective autophagy. Here we show that the expression of mHTT resistant to proteolysis at the caspase cleavage site D586 (C6R mHTT) increases autophagy, which may be due to its increased binding to the autophagy adapter p62. This is accompanied by faster degradation of C6R mHTT in vitro and a lack of mHTT accumulation the C6R mouse model with age. These findings may explain the previously observed neuroprotective properties of C6R mHTT. As the C6R mutation cannot be easily translated into a therapeutic approach, we show that a scheduled feeding paradigm is sufficient to lower mHTT levels in YAC128 mice expressing cleavable mHTT. This is consistent with a previous model, where the presence of cleavable mHTT impairs basal autophagy, while fasting-induced autophagy remains functional. In HD, mHTT clearance and autophagy may become increasingly impaired as a function of age and disease stage, because of gradually increased activity of mHTT-processing enzymes. Our findings imply that mHTT clearance could be enhanced by a regulated dietary schedule that promotes autophagy.
引用
收藏
相关论文
共 50 条
  • [11] Wild type huntingtin reduces the cellular toxicity of mutant huntingtin in mammalian cell models of Huntington's disease
    Ho, LW
    Brown, R
    Maxwell, M
    Wyttenbach, A
    Rubinsztein, DC
    JOURNAL OF MEDICAL GENETICS, 2001, 38 (07) : 450 - 452
  • [12] QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF
    Wild, Edward
    Robertson, Nicola
    Miller, James
    Traeger, Ulrike
    Haider, Salman
    Macdonald, Douglas
    Langbehn, Douglas
    Kuhn, Rainer
    Weiss, Andreas
    Tabrizi, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [13] Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models
    Schulze-Krebs, Anja
    Canneva, Fabio
    Stemick, Judith
    Plank, Anne-Christine
    Harrer, Julia
    Bates, Gillian P.
    Aeschlimann, Daniel
    Steffan, Joan S.
    von Hoersten, Stephan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [14] Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
    Xu, Hui
    Ajayan, Anakha
    Langen, Ralf
    Chen, Jeannie
    NEUROBIOLOGY OF DISEASE, 2025, 205
  • [15] Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
    Landles, Christian
    Sathasivam, Kirupa
    Weiss, Andreas
    Woodman, Ben
    Moffitt, Hilary
    Finkbeiner, Steve
    Sun, Banghua
    Gafni, Juliette
    Ellerby, Lisa M.
    Trottier, Yvon
    Richards, William G.
    Osmand, Alex
    Paganetti, Paolo
    Bates, Gillian P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (12) : 8808 - 8823
  • [16] Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
    Miller, John P.
    Holcomb, Jennifer
    Al-Ramahi, Ismael
    de Haro, Maria
    Gafni, Juliette
    Zhang, Ningzhe
    Kim, Eugene
    Sanhueza, Mario
    Torcassi, Cameron
    Kwak, Seung
    Botas, Juan
    Hughes, Robert E.
    Ellerby, Lisa M.
    NEURON, 2010, 67 (02) : 199 - 212
  • [17] NEURODEGENERATIVE DISEASE Preventing 'SIRTain' death by mutant huntingtin
    Flight, Monica Hoyos
    NATURE REVIEWS NEUROSCIENCE, 2012, 13 (02) : 71 - 71
  • [18] Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease
    Lu, Xiao-Hong
    Mattis, Virginia B.
    Wang, Nan
    Al-Ramahi, Ismael
    van den Berg, Nick
    Fratantoni, Silvina A.
    Waldvogel, Henry
    Greiner, Erin
    Osmand, Alex
    Elzein, Karla
    Xiao, Jingbo
    Dijkstra, Sipke
    de Pril, Remko
    Vinters, Harry V.
    Faull, Richard
    Signer, Ethan
    Kwak, Seung
    Marugan, Juan J.
    Botas, Juan
    Fischer, David F.
    Svendsen, Clive N.
    Munoz-Sanjuan, Ignacio
    Yang, X. William
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (268) : 268ra178
  • [19] Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice
    Caron, Nicholas S.
    Banos, Raul
    Aly, Amirah E.
    Xie, Yuanyun
    Ko, Seunghyun
    Potluri, Nalini
    Anderson, Christine
    Black, Hailey Findlay
    Anderson, Lisa M.
    Gordon, Benjamin
    Southwell, Amber L.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2022, 166
  • [20] Mutant huntingtin impairs immune cell migration in Huntington disease
    Kwan, Wanda
    Traeger, Ulrike
    Davalos, Dimitrios
    Chou, Austin
    Bouchard, Jill
    Andre, Ralph
    Miller, Aaron
    Weiss, Andreas
    Giorgini, Flaviano
    Cheah, Christine
    Moeller, Thomas
    Stella, Nephi
    Akassoglou, Katerina
    Tabrizi, Sarah J.
    Muchowski, Paul J.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (12): : 4737 - 4747